Another limitation and an outstanding research question in the current analysis is it was not designed to assess the contribution of exosomes in the neuropathology caused by COVID-19, which could transfer nucleic acids and cellular debris that could potentially trigger nucleic acid-responsive innate immune mechanisms, such as cGAS-STING and OAS. The gene discussed is CGAS; the disease is COVID-19.